Phase I Study of a Monoclonal Antibody for Treatment of Advanced Adenocarcinomas
Clinical trial NCT00051675 · COMPLETED
Trial details
- NCT number
- NCT00051675
- Sponsor
- XOMA (US) LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2002-07-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.